TL;DR Pi Cancer Care by Dr. Bharat Patodiya provides comprehensive CAR-T cell therapy evaluation and connects blood cancer patients with India's leading treatment centers, offering therapy at ₹30-50 lakhs compared to ₹3-4 crores internationally [1] India now has indigenous CAR-T therapy (NexCAR19) available at select centers including Tata Memorial Hospital, achieving 70-83% response rates in relapsed/refractory cases at one-tenth of international costs [4] Pi Cancer Care's C

TL;DR High blood cancer mortality persists due to late-stage diagnosis, with over 60% of patients presenting with advanced disease despite treatment breakthroughs [2] Treatment resistance mechanisms affect 30-40% of blood cancer patients, leading to relapse even after initial remission with modern therapies Pi Cancer Care by Dr.Bh arat Patodiya, personalized treatment protocols and real-time monitoring systems address key mortality factors through comprehensive patient evalua